Delayed-type hypersensitivity skin reactions by subcutaneous unfractionated and low molecular-weight heparins: Tolerance of a new recombinant hirudin
Koch P, Münßinger T, Rupp-John C, Uhl K. Delayed-type hypersensitivity skin reactions by subcutaneous unfractionated and low molecular-weight heparins: tolerance of a new recombinant hirudin. J Am Acad Dermatol 2000;42:612-619.
Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and danaparoid
Schiffner R, Glaessl A, Landthaler M, Stolz W. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and danaparoid. Contact Dermat 2000;42:49.
Eczematous infiltrated plaque to subcutaneous heparin: A type IV allergic reaction
Bircher AJ, Flückinger R, Büchner SA. Eczematous infiltrated plaque to subcutaneous heparin: a type IV allergic reaction. Br J Dermatol 1990;123:507-514.
Concomitant sensitisation to high and low molecular-weight heparins, heparinoids and pentosanpolysulfate
Hunzelmann N, Gold H, Scharffetter-Kochanek K. Concomitant sensitisation to high and low molecular-weight heparins, heparinoids and pentosanpolysulfate. Contact Dermat 1998;39:88-89.
Delayed-type hypersensitity and cross-reavtivity to heparins and danaparoid: A prospective study
Grassegger A, Fritsch P, Reider N. Delayed-type hypersensitity and cross-reavtivity to heparins and danaparoid: a prospective study. Dermatol Surg 2001;27:47-52.
The use of intravenous recombinant hirudin in lhe treatment of deap vein thrombosis in a patient with an acute heparin allergy
Fields RM, Peppo W. The use of intravenous recombinant hirudin in lhe treatment of deap vein thrombosis in a patient with an acute heparin allergy. Ann Emerg Med 2002;40:155-158.
Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy
Maetzke J, Hinrichs R, Staib G, Scharffetter-Kochanek K. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. Allergy 2004;59:237-238.